Clinical Trials Browser

Phase 2 × Osteosarcoma × Immune Checkpoint Inhibitors × Clear all

NCT04294511 2020-03-04

Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy in the Treatment of Osteosarcoma

Phase 2 Unknown

Osteosarcoma